CLINICAL TRIAL: PHASE I/II STUDY OF A BOOSTER DOSE OF A/H5N1/INDONESIA/05/05 (CL

临床试验：A/H5N1 加强剂量的 I/II 期研究/INDONESIA/05/05 (CL

• 批准号: 7951184
• 负责人: Wilbur H. Chen
• 金额: $ 24.51万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-03-01 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951184
• 关键词: Bird Flu vaccine; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Dose; Funding; Grant; Immune response; Indonesia; Institution; Phase; Phase I Clinical Trials; Placebos; Randomized; Research; Research Personnel; Resources; Safety; Source; United States National Institutes of Health; Vaccines; trial comparing

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is an NIH-sponsored multi-center phase 1-2 trial comparing the safety and immune responses of a clade 2 avian influenza vaccine in prior recipients of a clade 1 vaccine versus placebo. Subject are randomized to get either a low dose (15 ¿g) or a high dose (90 ¿g) of the vaccine.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以出现在其他 CRISP 条目中 列出的机构是。 对于中心来说，它不一定是研究者的机构。 这是一项由 NIH 赞助的多中心 1-2 期试验，比较了先前接种过 1 支疫苗的接种者与安慰剂接种者中的 2 支禽流感疫苗的安全性和免疫反应。受试者被随机分配接受低剂量（15 ¿）。 g) 或高剂量 (90 µg) 疫苗。